Efficacy and safety of switching etanercept to an anti-TNF monoclonal antibody in patients with juvenile idiopathic arthritis.

被引：0
|
作者：
Russo, Ricardo A. [1 ]
Katsicas, Maria M. [1 ]
机构：
[1] Hosp Pediat, Buenos Aires, DF, Argentina
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S681 / S682
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of anti-tnf treatment in patients with active refractory juvenile idiopathic arthritis
    Alexeyeva, E. I.
    Valieva, S. I.
    Bzarova, T. M.
    Alexeyeva, A. M.
    Afonina, E. U.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 173 - 174
  • [2] Safety of anti-TNFα therapy in children with juvenile idiopathic arthritis
    Dekker, L
    Armbrust, W
    Rademaker, CMA
    Prakken, B
    Kuis, W
    Wulffraat, NM
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (02) : 252 - 258
  • [3] Efficacy and safety of tocilizumab, an anti-IL-6 receptor monoclonal antibody; in patients with polyarticular or oligoarticular onset juvenile idiopathic arthritis.
    Imagawa, Tomoyuki
    Mori, Masaaki
    Takei, Syuji
    Kawano, Yoshifumi
    Iwata, Naomi
    Miyoshi, Mari
    Murata, Takuji
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    Yokota, Shumpei
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S168 - S168
  • [4] TREATMENT OF ADULT JUVENILE IDIOPATHIC ARTHRITIS PATIENTS WITH TNF BLOCKERS AND EFFECT OF SWITCHING TO A SECOND ANTI-TNF AGENT
    Jarosova, K.
    Chroust, K.
    Buresova, L.
    Vencovsky, J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S14 - S14
  • [5] TNF ALFA blocking treatment in adult patients with juvenile idiopathic arthritis. Clinical efficacy and safety
    Jarosova, K
    Svihalek, J
    Dusek, L
    Vencovsky, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 384 - 384
  • [6] Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis
    Arina Lazareva
    Valda Stanevicha
    Jelizaveta Semjonova
    Ruta Shantere
    Inita Buliņa
    Pediatric Rheumatology, 9 (Suppl 1)
  • [7] DISCONTINUATION OF ANTI-TNF IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS IN CLINICAL REMISSION
    Camacho-Lovillo, M.
    Gil-Gonzaez, E.
    Pedraza, M. A. Gantes
    Lopez-Sabido, M. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 388 - 388
  • [8] Onset of efficacy of anti-TNF alfa monoclonal antibody (remicade) in rheumatoid arthritis portuguese patients
    Vilar, A
    Araújo, D
    de Queiroz, MV
    Figueiredo, G
    Vaz, L
    André, R
    Moura, A
    Porto, A
    Quintal, A
    Branco, J
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 428 - 428
  • [9] Efficacy of anti-TNF therapy in subgroups of systemic-onset juvenile idiopathic arthritis
    Russo, R. A.
    Katsicas, M. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 567 - 567
  • [10] COST-EFFECTIVENESS OF USE OF ETANERCEPT VS THE ANTI-TNF MONOCLONAL ANTIBODY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN COSTA RICA
    Aguirre, A.
    Garcia, E.
    Bierschwale, H.
    Prado, M.
    VALUE IN HEALTH, 2009, 12 (07) : A522 - A522
12345